Patient-reported outcomes from a phase HI multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing alter chemotherapy: Cancer Oesophagus Gefitinib (COG)

Míreanna comhchosúla

• Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
  de réir: Dutton, S, et al.
  Foilsithe / Cruthaithe: (2014)
• Gefitinib and Epidermal Growth Factor Receptor Gene Copy Number Aberrations in Esophageal Cancer
  de réir: Petty, R, et al.
  Foilsithe / Cruthaithe: (2017)
• Gefitinib and EGFR gene copy number aberrations in esophageal cancer
  de réir: Petty, RD, et al.
  Foilsithe / Cruthaithe: (2017)
• Busting the Breast Cancer with AstraZeneca’s Gefitinib
  de réir: S. Chemmalar, et al.
  Foilsithe / Cruthaithe: (2023-01-01)
• Glycyrol Alone or in Combination with Gefitinib Is Effective against Gefitinib-Resistant HCC827GR Lung Cancer Cells
  de réir: Shuang Zhao, et al.
  Foilsithe / Cruthaithe: (2021-11-01)